[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2012/308587,2012,A1Locationinpatent:Page/Pagecolumn52
270065-76-4
270062-89-0
332061-83-3
269726-73-0
269726-76-3
331846-92-5
28020-38-4 | 6-Methoxypyridine-2,3-diamine | AA00I570 | MFCD06658229
298690-90-1 | (S)-2-(4-Fluorophenyl)pyrrolidine | AA00I5GH | MFCD06761856
308292-49-1 | 2-(3-Bromophenoxy)acetohydrazide | AA00I5PJ | MFCD02081890
31796-55-1 | H-Ala-pna hcl | AA00I5Y2 | MFCD00039088
325803-29-0 | Ethyl 3-amino-3-(4-chlorophenyl)propanoate, HCl | AA00I63N | MFCD00980051
330793-09-4 | 3-BOC-aminophenylboronic acid, pinacol ester | AA00I6AZ | MFCD03789256
338393-64-9 | 3-(2-(4-Fluorophenoxy)phenyl)acrylic acid | AA00I6L8 | MFCD02091006
34576-95-9 | 3,4-Dichloro-1-benzothiophene-2-carboxylic acid | AA00I6R5 | MFCD00617272
35351-35-0 | Methyl 5-methylfuran-3-carboxylate | AA00I6XY | MFCD11656598
362640-56-0 | 2-Methyl-4-(trifluoromethyl)benzonitrile | AA00I73X | MFCD13185724